[Budesonide in treatment of patients with cross primary biliary cirrhosis and autoimmune hepatitis].

Ėksperimental'naia i klinicheskaia gastroėnterologiia = Experimental & clinical gastroenterology

Volumn , Issue 8, 2010, Pages 113-117

  Golovanova, E V ^a   Khomeriki, S G ^a   Petrakov, A V ^a   Serova, T I ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BUDESONIDE; CHOLAGOGUE; URSODEOXYCHOLIC ACID;

ARTICLE; AUTOIMMUNE HEPATITIS; BILIARY CIRRHOSIS; DRUG COMBINATION; HUMAN; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS; BUDESONIDE; CHOLAGOGUES AND CHOLERETICS; DRUG THERAPY, COMBINATION; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER CIRRHOSIS, BILIARY; TREATMENT OUTCOME; URSODEOXYCHOLIC ACID;

EID: 79953657969     PISSN: 16828658     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)